PALO ALTO, Calif., Aug. 1 /PRNewswire/ -- Frost & Sullivan recognizes INOVA Diagnostics, Inc. with the 2007 North American Award for Market Leadership in the U.S. autoimmune disease diagnostic markets.
INOVA has been the only industry participant that has excelled in every aspect of autoimmune disease testing and continues to outpace the market with exceptional growth. In presenting this Award, Frost & Sullivan commends the company's dedication to excellence and quality in all its products and services.
"The company was founded in 1987 by research leaders which included those responsible for the very first commercial autoantibody test kits," notes Frost & Sullivan Research Analyst Kevin Leong. "Their exclusive dedication to autoimmune disease diagnostics has led to their undisputed leadership in this field."
With a broad range of customers that include large reference laboratories, esoteric test facilities, and esteemed medical research centers, INOVA is widely recognized and enjoys a reputation that is clearly reflected in its market success.
As the specialist in autoimmune disease diagnostics, INOVA provides products and services for every disease state. Its comprehensive test menu helps healthcare practitioners address common ailments such as rheumatoid arthritis and celiac diseases as well as rare disorders that include autoimmune hepatitis and Wegener's granulomatosis.
"The company is the only market leader that participates in all the segments of the autoimmune disease diagnostics market," explains Leong. "Clearly, with the increasing awareness of autoimmune diseases, INOVA is well poised to leverage its expertise and capitalize on growth across all the market segments."
In 2006, INOVA held the largest market share in the gastrointestinal autoimmune disease diagnostics market and the autoimmune liver disease diagnostics market. With a leading position in systemic autoimmune disease diagnostics as well, INOVA nurtured the growth of a revolutionary marker for rheumatoid arthritis, cyclic citrullinated peptide (CCP) antibody, and continues to be the leading provider of anti-CCP tests in the country.
All products are produced in INOVA's sole base of operations in San Diego, CA, allowing for full quality control on every shipment. In addition, by selling directly to the clinical laboratory, the company avoids any complex distribution structure that can negatively impact loyalty, reliability, and costs. Truly, INOVA strives to deliver optimum test solutions and values its relationships with each and every client.
The company's market performance stems from the reputation it has earned as a result of its commitment to excellence in quality and customer support. With an ever-expanding R&D pipeline that is brimming with innovative test solutions, INOVA is certain to maintain its leadership in autoimmune disease diagnostics and capture further markets.
The Frost & Sullivan Award for Market Leadership is presented to the company that has exhibited market share leadership through the implementation of market strategy. The recipient has displayed excellence in all areas of the market leadership process, including the identification of market challenges, drivers and restraints, as well as strategy development and methods of addressing these market dynamics. Furthermore, the Award recipient has continually demonstrated solutions for monitoring market changes and for implementing superior market strategies.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About INOVA Diagnostics, Inc.
INOVA Diagnostics, Inc. is dedicated exclusively to autoimmune disease diagnostics. Our single focus allows us to offer unmatched quality, reliable consistency and excellent value on the most comprehensive menu of autoimmune disease testing reagents available anywhere. INOVA's autoimmune product groups include kits and components for testing in the areas of connective tissue disease, rheumatoid arthritis, celiac disease, coagulation, gastrointestinal disorders, vasculitis, endocrine, autoimmune liver disease and related infectious diseases. Among the many customers who rely on INOVA to meet their growing autoimmune testing needs are America's largest clinical laboratory systems, regional reference facilities, and many of the nation's most prestigious medical centers and universities. In addition, INOVA reagents are sold in more than 90 countries around the world. INOVA's unique commitment to autoimmune disease diagnostic testing is reflected in the extraordinary level of technical proficiency, product support and in the impeccable service we provide to all our customers.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.awards.frost.com or http://www.drugdiscovery.frost.com.
Frost & Sullivan